Esophagus to Small Intestine

Aliment Pharmacol Ther. 2026;63(8):1151-1161

Alsakarneh S, Al Ta’ani O, Madi MY, Syn WK, Ruffle JK, Aziz Q, Farmer AD

Comprehensive risk profile of gastrointestinal and extra articular comorbidities in Ehlers-Danlos syndrome: A propensity-matched analysis of 118,256 individuals


Background: Ehlers-Danlos syndrome (EDS) comprises inherited connective tissue disorders characterised by joint hypermobility, skin hyperextensibility and tissue fragility. It links to systemic comorbidities, including gastrointestinal (GI) disorders, but hitherto large-scale data remain limited. We aimed to evaluate the prevalence of GI, systemic and psychological comorbidities in EDS patients versus propensity score-matched controls, using a comprehensive research network database.
Design: This was a retrospective, propensity-matched analysis (2005–2023) utilising the TriNetX network. We identified EDS patients (excluding Marfan’s syndrome). Propensity score matching (1:1) generated balanced cohorts for age, sex and baseline characteristics. Comorbidities were analysed via prevalence rates and odds ratios (ORs) with 95% confidence intervals (CIs).
Results: Matched cohorts included 59,128 pairs. Among GI disorders, gastroesophageal reflux disease was most common in EDS (18.4%, OR = 1.5, 95% CI: 1.4–1.5, p < 0.001), followed by constipation (12.4%, OR = 1.8, 95% CI: 1.7–1.9, p < 0.001), irritable bowel syndrome (7.3%, OR = 2.6, 95% CI: 2.5–2.8, p < 0.001) and gastroparesis (4.7%, OR = 8.2, 95% CI: 7.3–9.2, p < 0.001). Psychiatric conditions showed heightened prevalence of anxiety (26.1%, OR = 1.8, 95% CI: 1.7–1.8, p < 0.001) and depression (18.7%, OR = 1.3, 95% CI: 1.2–1.3, p < 0.001). Systemic comorbidities included postural orthostatic tachycardia syndrome (13.2%, OR = 899.7, 95% CI: 483.8–1673.0, p < 0.001), chronic pain (7.9%, OR = 7.0, 95% CI: 6.4–7.6, p < 0.001), migraines (19.7%, OR = 2.5, 95% CI: 2.4–2.6, p < 0.001) and fibromyalgia (9.5%, OR = 1.7, 95% CI: 1.6–1.8, p < 0.001).

Conclusion: EDS patients exhibit heightened risk for GI, systemic and psychological comorbidities, highlighting the importance of multidisciplinary approaches for effective management.

A.D. Farmer, Division of Gastroenterology and Hepatology, Saint Louis University School of Medicine, St. Louis, MO, USA, e-mail: adamdonald.farmer@ssmhealth.com

DOI:  10.1111/apt.70506

Back to overview

this could be of interest:

More articles on the topic